[Oxyquinoline derivatives for peroral use will disappear from the market].
D000284:Administration, Oral; D001424:Bacterial Infections / Q000188:drug therapy; D003718:Denmark; D004404:Dysentery, Amebic / Q000188:drug therapy; D006801:Humans; D006912:Hydroxyquinolines / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D007880:Legislation, Drug; D009422:Nervous System Diseases / Q000139:chemically induced*
D006912:Hydroxyquinolines
Oksikinolinderivater til peroral brug traekkes ud af handelen.